ASSOCIATION OF GLP-1 AGONISTS WITH ARRHYTHMIAS AND SUDDEN CARDIAC DEATH IN PATIENTS WITH TYPE 2 DIABETES: A META-ANALYSIS OF 27 RANDOMIZED CONTROLLED TRIALS

被引：0
|
作者：
Al-Sadawi, Mohammed [1 ]
Aslam, Faisal [1 ]
Aleem, Saadat [1 ]
Alsadaoee, Maryam [1 ]
Stevens, Gregg Alexander [1 ]
Singh, Abhijeet [1 ]
Almasry, Ibrahim O. [1 ]
Rashba, Eric J. [1 ]
Fan, Roger [1 ]
机构：
[1] Stony Brook Med, Stony Brook, NY USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2022年 / 79卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1525 / 1525
页数：1
相关论文
共 50 条
  • [1] GLP-1 receptor agonists and risk of cancer in type 2 diabetes: an updated meta-analysis of randomized controlled trials
    Chuqing Cao
    Shuting Yang
    Zhiguang Zhou
    Endocrine, 2019, 66 : 157 - 165
  • [2] GLP-1 receptor agonists and risk of cancer in type 2 diabetes: an updated meta-analysis of randomized controlled trials
    Cao, Chuqing
    Yang, Shuting
    Zhou, Zhiguang
    ENDOCRINE, 2019, 66 (02) : 157 - 165
  • [3] Association of SGLT2 inhibitors with arrhythmias and sudden cardiac death in patients with type 2 diabetes or heart failure: A meta-analysis of 34 randomized controlled trials
    Fernandes, Gilson C.
    Fernandes, Amanda
    Cardoso, Rhanderson
    Penalver, Jorge
    Knijnik, Leonardo
    Mitrani, Raul D.
    Myerburg, Robert J.
    Goldberger, Jeffrey J.
    HEART RHYTHM, 2021, 18 (07) : 1098 - 1105
  • [4] A meta-analysis evaluating indirectly GLP-1 receptor agonists and arrhythmias in patients with type 2 diabetes and myocardial infarction
    Liu, Zhijie
    Bian, Ning
    Wu, Shaorong
    Fan, Yiming
    Li, Hairui
    Yu, Jian
    Guo, Jun
    Chen, Dongdong
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [5] GLP-1 Receptor Agonists and Risk of Adverse Cerebrovascular Outcomes in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Banerjee, Mainak
    Pal, Rimesh
    Mukhopadhyay, Satinath
    Nair, Kirthana
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (07): : 1806 - 1812
  • [6] GLP-1 receptor agonists and HBA1c target of <7% in type 2 diabetes: meta-analysis of randomized controlled trials
    Esposito, K.
    Mosca, C.
    Brancario, C.
    Chiodini, P.
    Ceriello, A.
    Giugliano, D.
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (08) : 1519 - 1528
  • [7] Effects of GLP-1 receptor agonists on arrhythmias and its subtypes in patients with type 2 diabetes: A systematic review and meta-analysis
    Wei, Jinjing
    Wang, Ruxin
    Ye, Haowen
    Wang, Ying
    Wang, Lihong
    Zhang, Xiaofang
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [8] THE EFFECT OF GLP-1 AGONISTS IN PATIENTS WITH TYPE 2 DIABETES ON ALL-CAUSE MORTALITY AND CARDIOVASCULAR MORTALITY: AN UPDATED META-ANALYSIS OF 44 RANDOMIZED CONTROLLED TRIALS
    Al-Sadawi, Mohammed
    Aslam, Faisal
    Aleem, Saadat
    Alsadaoee, Maryam
    Alexander, Stevens Gregg
    Singh, Abhijeet
    Almasry, Ibrahim O.
    Fan, Roger
    Rashba, Eric J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1542 - 1542
  • [9] Association of glucagon-like peptide-1 receptor agonists with cardiac arrhythmias in patients with type 2 diabetes or obesity: a systematic review and meta-analysis of randomized controlled trials
    Wu, Sijin
    Lu, Wenzhao
    Chen, Zhongli
    Dai, Yan
    Chen, Keping
    Zhang, Shu
    DIABETOLOGY & METABOLIC SYNDROME, 2022, 14 (01):
  • [10] Association of glucagon-like peptide-1 receptor agonists with cardiac arrhythmias in patients with type 2 diabetes or obesity: a systematic review and meta-analysis of randomized controlled trials
    Sijin Wu
    Wenzhao Lu
    Zhongli Chen
    Yan Dai
    Keping Chen
    Shu Zhang
    Diabetology & Metabolic Syndrome, 14
12345